相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2
Ren-Di Jiang et al.
CELL (2020)
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Yixuan J. Hou et al.
CELL (2020)
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets
Young-Il Kim et al.
CELL HOST & MICROBE (2020)
A Mouse Model of SARS-CoV-2 Infection and Pathogenesis
Shi-Hui Sun et al.
CELL HOST & MICROBE (2020)
COVID-19: lambda interferon against viral load and hyperinflammation
Evangelos Andreakos et al.
EMBO MOLECULAR MEDICINE (2020)
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
Barry Rockx et al.
SCIENCE (2020)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Sin Fun Sia et al.
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
Respiratory disease in rhesus macaques inoculated with SARS-CoV-2
Vincent J. Munster et al.
NATURE (2020)
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
Linlin Bao et al.
NATURE (2020)
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment
Jing Sun et al.
CELL (2020)
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Ahmed O. Hassan et al.
CELL (2020)
Inhibition of SARS-CoV-2 by type I and type III interferons
Ulrike Felgenhauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Benjamin Israelow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform
Sudhakar Agnihothram et al.
JOURNAL OF VIROLOGY (2018)
Uncovering inherent cellular plasticity of multiciliated ependyma leading to ventricular wall transformation and hydrocephalus
Khadar Abdi et al.
NATURE COMMUNICATIONS (2018)
Emerging concepts for the treatment of hepatitis delta
Menashe Elazar et al.
CURRENT OPINION IN VIROLOGY (2017)
IFN-lambda preferably inhibits PEDV infection of porcine intestinal epithelial cells compared with IFN-alpha
Lin Li et al.
ANTIVIRAL RESEARCH (2017)
IFN is a potent anti-influenza therapeutic without the inflammatory side effects of IFN treatment
Sophia Davidson et al.
EMBO MOLECULAR MEDICINE (2016)
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
Henry L. Y. Chan et al.
JOURNAL OF HEPATOLOGY (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
SARS-like WIV1-CoV poised for human emergence
Vineet D. Menachery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Vineet D. Menachery et al.
NATURE MEDICINE (2015)
New Metrics for Evaluating Viral Respiratory Pathogenesis
Vineet D. Menachery et al.
PLOS ONE (2015)
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Andrew J. Muir et al.
JOURNAL OF HEPATOLOGY (2014)
Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness
Jianhua Sui et al.
JOURNAL OF VIROLOGY (2014)
Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
Trevor Scobey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus
Barry Rockx et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections
Markus Mordstein et al.
JOURNAL OF VIROLOGY (2010)
Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge
Barry Rockx et al.
JOURNAL OF VIROLOGY (2008)
Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus
Paul B. McCray et al.
JOURNAL OF VIROLOGY (2007)
A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice
Anjeanette Roberts et al.
PLOS PATHOGENS (2007)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans
A Roberts et al.
JOURNAL OF VIROLOGY (2005)
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus
B Yount et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter
LE Ostrowski et al.
MOLECULAR THERAPY (2003)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
分享论文
